Related Experiment Video
Updated: Aug 9, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis
Finn E von Eyben1, Karsten Kristiansen2,3,4, Daniel S Kapp5
1Center for Tobacco Control Research, Birkevej 17, 5230 Odense, Denmark.
Abstract:
In testicular germ cell tumor type II (TGCT), a seminoma subtype expresses an induced pluripotent stem cell (iPSC) panel with four upregulated genes, OCT4/POU5F1, SOX17, KLF4, and MYC, and embryonal carcinoma (EC) has four upregulated genes, OCT4/POU5F1, SOX2, LIN28, and NANOG. The EC panel can reprogram cells into iPSC, and both iPSC and EC can differentiate into teratoma. This review summarizes the literature on epigenetic regulation of the genes. Epigenetic mechanisms, such as methylations of cytosines on the DNA string and methylations and acetylations of histone 3 lysines, regulate expression of these driver genes between the TGCT subtypes. In TGCT, the driver genes contribute to well-known clinical characteristics and the driver genes are also important for aggressive subtypes of many other malignancies. In conclusion, epigenetic regulation of the driver genes are important for TGCT and for oncology in general.
Insights
Epigenetic regulation influences key genes in testicular germ cell tumors (TGCT). Understanding these mechanisms is crucial for TGCT and broader oncology research.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Testicular germ cell tumors (TGCT) encompass subtypes like seminoma and embryonal carcinoma (EC).
- Specific gene panels, including OCT4/POU5F1, SOX17, KLF4, MYC (seminoma), and OCT4/POU5F1, SOX2, LIN28, NANOG (EC), are associated with TGCT subtypes.
- Both induced pluripotent stem cells (iPSC) and EC can differentiate into teratomas, highlighting stem cell-like properties.
Purpose of the Study:
- To review the literature on the epigenetic regulation of key genes in TGCT.
- To elucidate the role of epigenetic mechanisms in differential gene expression between TGCT subtypes.
- To connect the function of these genes in TGCT to their broader implications in oncology.
Main Methods:
- Literature review focusing on epigenetic mechanisms.
- Analysis of gene expression patterns in TGCT subtypes (seminoma and EC).
- Examination of epigenetic modifications, including DNA methylation and histone modifications.
Main Results:
- Seminoma and EC subtypes of TGCT exhibit distinct upregulated gene panels.
- Epigenetic mechanisms, such as DNA cytosine methylation and histone 3 lysine methylation/acetylation, regulate these driver genes.
- These driver genes are implicated in the clinical characteristics of TGCT and aggressive cancer subtypes.
Conclusions:
- Epigenetic regulation plays a critical role in the distinct gene expression profiles of TGCT subtypes.
- The identified driver genes are fundamental to TGCT pathogenesis and progression.
- Understanding epigenetic regulation in TGCT offers insights applicable to oncology in general.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

